“Analytics are becoming more predictive, programmatic, and intuitive for pharmaceutical companies, and it’s now possible to deliver alerts and next-best actions seamlessly,” says Leilani Latimer, VP Global Marketing, Zephyr Health. “Solutions that anticipate market needs
“Without a doubt, leveraging advanced analytics presents a real and significant opportunity for the pharmaceutical industry,” reports McKinsey in a 2018 article. Pharmaceutical companies know this, they just don’t know how to achieve and quantify
A pharmaceutical sales brag book remains as important today in the interview process as it was when this blog was originally written in 2017. The difference? As with many things over the past year the
“Biomanufacturing isn’t just about making our current materials more cheaply,” says John Cumbers, a biologist and founder of SynBioBeta, an activity hub for synthetic biology start-up companies. “It is also about bringing incredible new products
COVID-19 has made 63% of organizations embrace digital transformation sooner than they had expected as reported in a survey by Celerity.com. A similar number said they were making greater investments in technology sooner due to
Sometimes previous blogs just keep cropping up as interesting and relevant. Our blog on pharmaceutical analytics evolution keeps coming to the top of the feed. Here it is, slightly refreshed, for your reading pleasure. Pharmaceutical
